https://www.selleckchem.com/pr....oducts/orelabrutinib
Gene set enrichment analysis (GSEA) revealed that DCBLD2 overexpression induces epithelial-mesenchymal transition (EMT) and activates the JAK/STAT3 pathway. CONCLUSIONS We found that high DCBLD2 expression correlated with a poor clinical outcome, as well as tumorigenesis, invasion and metastasis of CRC cells. DCBLD2 may serve as a prognostic biomarker and a novel therapeutic target for CRC.BACKGROUND 44Sc has been increasingly investigated as a potential alternative to 68Ga in the development of tracers for positron emission tomog
Like
Comment
Share
